Medical Condition

crohn s disease

Total Trials

12

Recruiting Now

12

Trial Phases

Phase 3, Phase 2

ClinicalMetric tracks all active clinical trials for crohn s disease sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — crohn s disease Clinical Trials

How many clinical trials are currently recruiting for crohn s disease?

ClinicalMetric currently tracks 12 actively recruiting clinical trials for crohn s disease, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 12. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for crohn s disease?

crohn s disease research spans Phase 2 (2 trials), Phase 3 (4 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a crohn s disease clinical trial?

Eligibility criteria for crohn s disease trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 2

Phase 3

Top Sponsors

Sanofi 2 trials

Takeda 2 trials

University of Hertfordshire 1 trial

Asan Medical Center 1 trial

Eli Lilly and Company 1 trial

Recruiting Clinical Trials

NCT06211400

Recruiting

Vibration Exercise for Crohn's to Observe Response

University of Hertfordshire

View Trial →

NCT06064864

Recruiting

Efficacy and Safety of Formulation Switching Between SC Infliximab and IV Infliximab in Patients With CD

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

Enrollment

90 pts

Location

United States, Austr...

Sponsor

Eli Lilly and Company

View Trial →

NCT06023030

Recruiting

An Observational Study to Assess Change in Disease Activity and Adverse Events in Adolescent and Adult Participants With Moderate to Severe Active Crohn's Disease (CD) in Japan

Impact of Diet and Lifestyle Modification on the Intestinal Barrier Integrity in Crohn's Disease

Universität Duisburg-Essen

View Trial →

NCT07184931 Phase 3

Recruiting

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Enrollment

980 pts

Location

United States, Argen...

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

Enrollment

99 pts

Location

United States, Austr...

A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

Enrollment

192 pts

Location

United States, China...

Longitudinal Study on Bacterial Production of LPC and LPA in Patients With Inflammatory Bowel Disease

A Survey of Darvadstrocel in People With Crohn's Disease

Use of Crohn's Disease Exclusion Diet on Top of Standard Therapy Versus Standard Therapy Alone in Unstable Pediatric Crohn's Disease Patients.

Assistance Publique - Hôpitaux...

View Trial →

NCT05923073 Phase 3

Recruiting

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

Enrollment

120 pts

Location

United States, Austr...

Sponsor

Janssen Research & Development...

View Trial →

Related Conditions

ulcerative colitis (2) inflammatory bowel diseases (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology